Stockreport

SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates

SAB Biotherapeutics, Inc.  (SABS) 
PDF Recently raised $175 million in oversubscribed private placement which included strategic investor Sanofi and top-tier biotech investors Strong cash position with com [Read more]